JP2023548118A5 - - Google Patents
Info
- Publication number
- JP2023548118A5 JP2023548118A5 JP2023526012A JP2023526012A JP2023548118A5 JP 2023548118 A5 JP2023548118 A5 JP 2023548118A5 JP 2023526012 A JP2023526012 A JP 2023526012A JP 2023526012 A JP2023526012 A JP 2023526012A JP 2023548118 A5 JP2023548118 A5 JP 2023548118A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063107992P | 2020-10-30 | 2020-10-30 | |
| US63/107,992 | 2020-10-30 | ||
| PCT/US2021/057363 WO2022094284A1 (en) | 2020-10-30 | 2021-10-29 | Methods of administering genetically modified b cells for in vivo delivery of therapeutic agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023548118A JP2023548118A (ja) | 2023-11-15 |
| JPWO2022094284A5 JPWO2022094284A5 (https=) | 2024-11-06 |
| JP2023548118A5 true JP2023548118A5 (https=) | 2024-11-06 |
Family
ID=81383286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526012A Pending JP2023548118A (ja) | 2020-10-30 | 2021-10-29 | 治療剤のｉｎ ｖｉｖｏ送達のために、遺伝子改変Ｂ細胞を投与する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230414659A1 (https=) |
| EP (1) | EP4236968A4 (https=) |
| JP (1) | JP2023548118A (https=) |
| CN (1) | CN116490203A (https=) |
| AU (1) | AU2021368725A1 (https=) |
| CA (1) | CA3196239A1 (https=) |
| WO (1) | WO2022094284A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4709867A1 (en) * | 2023-05-08 | 2026-03-18 | The Regents of the University of California | Targeted viral transduction of b cells |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4659092B2 (ja) * | 2005-04-18 | 2011-03-30 | エーシーティーエックス，インコーポレイテッド | 損傷組織へのｂ細胞投与による組織機能の回復 |
| CN105377039A (zh) * | 2013-05-15 | 2016-03-02 | 明尼苏达大学董事会 | 腺相关病毒介导的基因向中枢神经系统转移 |
| DK3234107T3 (da) * | 2014-12-19 | 2022-10-17 | Immusoft Corp | B-celler til in vivo-levering af terapeutiske midler |
| EP3411488A1 (en) * | 2016-02-03 | 2018-12-12 | The Trustees Of The University Of Pennsylvania | Gene therapy for treating mucopolysaccharidosis type i |
| NZ758331A (en) * | 2017-04-27 | 2025-12-19 | Immusoft Corp | B cells for in vivo delivery of therapeutic agents and dosages thereof |
| US20210207167A1 (en) * | 2018-05-16 | 2021-07-08 | Voyager Therapeutics, Inc. | Aav serotypes for brain specific payload delivery |
| US20220079986A1 (en) * | 2019-01-23 | 2022-03-17 | The General Hospital Corporation | B cell immunotherapy |
-
2021
- 2021-10-29 EP EP21887642.3A patent/EP4236968A4/en active Pending
- 2021-10-29 CA CA3196239A patent/CA3196239A1/en active Pending
- 2021-10-29 AU AU2021368725A patent/AU2021368725A1/en active Pending
- 2021-10-29 US US18/034,865 patent/US20230414659A1/en active Pending
- 2021-10-29 JP JP2023526012A patent/JP2023548118A/ja active Pending
- 2021-10-29 WO PCT/US2021/057363 patent/WO2022094284A1/en not_active Ceased
- 2021-10-29 CN CN202180074274.3A patent/CN116490203A/zh active Pending